Why the study?
Does anti-inflammatory therapy (aspirin and/or statin) improve weight loss in patients with Type 2 diabetes mellitus?
Population
202 patients with Type 2 diabetes mellitus
Comparison
Anti-inflammatory therapy (aspirin and/or statin) vs No exposure to anti-inflammatory therapy
Design
Case-control
Follow-up
1-year
Authors
Loading...
Supports potential weight loss benefit in T2DM; hypothesis-generating and requires randomized confirmation before practice change.
Does anti-inflammatory therapy (aspirin and/or statin) improve weight loss in patients with Type 2 diabetes mellitus?
Exposure to aspirin and/or statins is associated with more than doubled odds of weight loss in patients with Type 2 diabetes mellitus.
Boaz et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: